Renal sympathetic nervous system hyperactivity in early streptozotocin-induced diabetic kidney disease

Neurourology and Urodynamics

Volumn 30, Issue 3, 2011, Pages 438-446

  Salman, Ibrahim M ^a   Ameer, Omar Z ^a   Sattar, Munavvar A ^a   Abdullah, Nor A ^b   Yam, Mun F ^a,c   Abdullah, Ghassan Z ^a   Abdulkarim, Muthanna F ^a   Khan, Md Abdul Hye ^d   Johns, Edward J ^e  

^a SCHOOL OF PHARMACEUTICAL SCIENCES   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Diabetic kidney disease; Renal denervation; Renal nerve stimulation; Renal sympathetic nerve; Streptozotocin

Indexed keywords

CREATININE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; KIDNEY BLOOD FLOW; KIDNEY DENERVATION; KIDNEY FUNCTION; KIDNEY NERVE; KIDNEY VASCULAR RESISTANCE; MALE; NERVE STIMULATION; NONHUMAN; RAT; SODIUM BALANCE; SODIUM EXCRETION; STREPTOZOCIN DIABETES; SYMPATHETIC INNERVATION; SYMPATHETIC TONE; URINALYSIS; VASOCONSTRICTION;

ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; BLOOD PRESSURE; CREATININE; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; ELECTRIC STIMULATION; GLOMERULAR FILTRATION RATE; KIDNEY; MALE; RATS; RATS, SPRAGUE-DAWLEY; RENAL CIRCULATION; SODIUM; SYMPATHECTOMY; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS; VASCULAR RESISTANCE;

EID: 79952771945     PISSN: 07332467     EISSN: 15206777     Source Type: Journal    
DOI: 10.1002/nau.21007     Document Type: Article

References (43)

1. U.S. Renal Data System. Excerpts from the USRDS 2000 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis 2000;36:S1-238.
2. Parving HH, Osterby R, Ritz E. Diabetic nephropathy. In: Brenner and Rector's The Kidney, 6th ed. WB Saunders Company; 2000. p 1731-73.
3. Viberti G, Wiseman MJ, Pinto JR, Messent J. Diabetic nephropathy. In: Joslin's Diabetic Nephropathy, 13th ed. Philadelphia: Lippincott Williams & Wilkins; 1994. p 691-737.
4. Viberti G. Why do we have to invoke genetic susceptibility for diabetic nephropathy? Kidney Int 1999;55:2526-7.
5. Sullivan JL. Iron and the genetics of cardiovascular disease. Circulation 1999;100:1260-3. (Pubitemid 29440115)
6. Orloff LA, Orloff MS, Orloff SL, Orloff MJ. Lifelong prevention of mesangial enlargement by whole pancreas transplantation in rats with diabetes mellitus. Arch Surg 1999;134:889-97. (Pubitemid 29372831)
7. Lewis J, Lewis EJ. In memory of a legendary athlete: Measured successes in diabetic nephropathy. Semin Nephrol 2001;21:124-32.
8. Christiansen JS, Gammelgaard J, Tronier B, Svendsen PA, Parving HH. Kidney function and size in diabetics before and during initial insulin treatment. Kidney Int 1986;21:683-8.
9. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986;46:201-6. (Pubitemid 16011235)
10. Hostetter TH, Troy JL, Brenner BM. Glomerular hemodynamics in experimental diabetes mellitus. Kidney Int 1981;19:410-5. (Pubitemid 11112621)
11. Luippold G, Beilharz M, Mühlbauer B. Chronic renal denervation prevents glomerular hyperfiltration in diabetic rats. Nephrol Dial Transplant 2004;19:342-7. (Pubitemid 38195982)
12. Salman IM, Sattar MA, Abdullah NA, Ameer OZ, Salman HM, Abdulla MH, Basri F, Hussain NM, Yam MF, Sriramaneni RN, Anand Swarup KRL, Rathore HA, Kazi RN, Khan MAH, Johns EJ. Renal function and hemodynamics in recent onset type 1 diabetes mellitus in Sprague-Dawley rats. Pharmacologyonline 2009;2:546-56.
13. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984;311:89-93. (Pubitemid 14084080)
14. Tucker BJ, Collins RC, Ziegler MG, Blantz RC. Disassociation between glomerular hyperfiltration and extracellular volume in diabetic rats. Kidney Int 1991;39:1176-83.
15. O'Bryan GT, Hostetter TH. The renal hemodynamic basis of diabetic nephropathy. Semin Nephrol 1997;17:93-100. (Pubitemid 27124034)
16. Vallon V, Blantz RC, Thomson S. Glomerular hyperfiltration and the salt paradox in early type 1 diabetes mellitus: A tubulo-centric view. J Am Soc Nephrol 2003;14:530-7. (Pubitemid 36150878)
17. Komers R, Anderson S. Paradoxes of nitric oxide in the diabetic kidney. Am J Physiol Renal Physiol 2003;284:F1121-37.
18. Joles JA, Koomans HA. Causes and consequences of increased sympathetic activity in renal disease. Hypertension 2004;43:699-706. (Pubitemid 38405571)
19. Christiansen JS. On the pathogenesis of the increased glomerular filtration rate in short-term insulin-dependent diabetes. Dan Med Bull 1984;31:349-61. (Pubitemid 14049222)
20. Salman IM, Sattar MA, Abdullah NA, Ameer OZ, Abdulla MH, Basri F, Hussain NM, Khan MAH, Yam MF, Anand Swarup KRL, Rathore HA, Kazi RN, Sriramaneni RN, Johns EJ. Role of the renal sympathetic nerve activity in mediating renal hemodynamic alterations in rat models of renal impairment. Adv Clin Exp Med 2009;18:205-14.
21. Salman IM, Ameer OZ, Sattar MA, Abdullah NA, Yam MF, Najim HS, Abdulkarim MF, Abdullah GZ, Kaur G, Khan MAH, Johns EJ. Characterization of renal hemodynamic and structural alterations in rat models of renal impairment: Role of renal sympathoexcitation. J Nephrol (in press).
22. Salman IM, Ameer OZ, Sattar MA, Abdullah NA, Yam MF, Najim HS, Khan MAH, Johns EJ. Role of the renal sympathetic nervous system in mediating renal ischemic injury-induced reductions in renal hemodynamic and excretory functions. Pathology 2010;42:259-66.
23. Salman IM, Sattar MA, Abdullah NA, Ameer OZ, Kaur G, Yam MF, Khan MAH, Johns EJ. Renal ischemic injury affects renal hemodynamics and excretory functions in Sprague Dawley rat: Involvement of renal sympathetic tone. Ren Fail 2010;32:96-102.
24. Salman IM, Sattar MA, Abdullah NA, Ameer OZ, Basri F, Hussain NM, Khan MAH, Yam MF, Anand Swarup KRL, Rathore HA, Kazi RN, Salman HM, Johns EJ. Renal functional and haemodynamic changes following acute unilateral renal denervation in Sprague Dawley rats. Indian J Med Res 2010;131:76-82.
25. Usui H, Shikata K, Matsuda M, Okada S, Ogawa D, Yamashita T, Hida K, Satoh M, Wada J, Makino H. HMG-CoA reductase inhibitor ameliorates diabetic nephropathy by its pleiotropic effects in rats. Nephrol Dial Transpl 2003;18:265-72. (Pubitemid 36181675)
26. Yin XX, Zhang YD, Shen JP, Wu HW, Zhu X, Li LM, Qiu J, Jiang SJ, Zheng XG. Protective effects of bendazac lysine on early experimental diabetic nephropathy in rats. Acta Pharmacol Sin 2005;26:721-8. (Pubitemid 40806562)
27. Zanchetti A, Stella A. Cardiovascular diseases and the kidney: An epidemiological overview. J Cardiovasc Pharmacol 1999;33:S1-6.
28. Koda-Kimble MA, Young LY, Kradjan WA, Guglielmo BJ, Alldredge BK. Applied therapeutics: The clinical use of drugs, 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2005.
29. O'Hagan M, Howey S, Greene SA. Increased proximal tubular reabsorption of sodium in childhood diabetes mellitus. Diabet Med 1991;8:44-8.
30. Vrbjar N, Strelkova S, Stefek M, Kyselova Z, Gajdosikova A. Effect of the pyridoindole antioxidant stobadine on sodium handling of renal Na, K-ATPase in rats with streptozotocin-induced diabetes. Acta Diabetol 2004;41:172-8.
31. +)-ATPase activity in proximal tubules of spontaneously hypertensive rats. Kidney Int 1990;38:402-8.
32. Schnermann J, Briggs J. Concentration-dependent sodium chloride transport as the signal in feedback control of glomerular filtration rate. Kidney Int 1982;22:S82-9.
33. Schnermann J, Ploth DW, Hermle M. Activation of tubuloglomerular feedback by chloride transport. Pflugers Arch 1976;362:229-40.
34. Vallon V, Osswald H, Blantz RC, Thomson SC. Potential role of luminal potassium in tubuloglomerular feedback. J Am Soc Nephrol 1997;8:1831-7. (Pubitemid 28185440)
35. Hollenberg NK, Adams DF, Solomon H, Chenitz WR, Burger BM, Abrams HL, Merrill JP. Renal vascular tone in essential and secondary hypertension: Hemodynamic and angiographic responses to vasodilators. Medicine 1975;54:29-44.
36. Bohm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J 1997;322:1-18.
37. 1aAR splice variants. J Biol Chem 2002;277:9570-9.
38. Abdul Sattar M, Johns EJ. Alpha1-adrenoceptor subtypes mediating adrenergic vasoconstriction in kidney, one-clip Goldblatt and deoxycorticosterone acetate-salt hypertensive rats. J Cardiovasc Pharmacol 1994;24:420-8. (Pubitemid 24260522)
39. Salomonsson M, Brännström K, Arendshorst WJ. Alpha(1)-adrenoceptor subtypes in rat renal resistance vessels: In vivo and in vitro studies. Am J Physiol Renal Physiol 2000;278:F138-47.
40. Khan AH, Sattar MA, Abdullah NA, Johns EJ. Influence of cisplatin-induced renal failure on the alpha(1)-adrenoceptor subtype causing vasoconstriction in the kidney of the rat. Eur J Pharmacol 2007;569:110-8.
41. Krayacich J, Kline RL, Mercer PF. Supersensitivity to NE alters renal function of chronically denervated rat kidneys. Am J Physiol 1987;252:F856-64.
42. Ramchandra R, Barrett CJ, Guild SJ, Malpas SC. Is the chronically denervated kidney supersensitive to catecholamines? Am J Physiol 2002;282:R603-10.
43. Langer SZ. Proceedings: Pre and postsynaptic components of supersensitivity induced by surgical sympathetic denervation. Acta Physiol Lat Am 1973;23:604-6.